FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.
- DOI
- 10.1177/00912709922008515
- Published
- 1999 Sep
- Container
- Journal of clinical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/00912709922008515,
title = {FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.},
author = {Davit B and Reynolds K and Yuan R and Ajayi F and Conner D and Fadiran E and Gillespie B and Sahajwalla C and Huang SM and Lesko LJ},
year = {1999},
journal = {Journal of clinical pharmacology},
doi = {10.1177/00912709922008515},
url = {https://doi.org/10.1177/00912709922008515}
}RIS
TY - JOUR TI - FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling. AU - Davit B AU - Reynolds K AU - Yuan R AU - Ajayi F AU - Conner D AU - Fadiran E AU - Gillespie B AU - Sahajwalla C AU - Huang SM AU - Lesko LJ PY - 1999 JO - Journal of clinical pharmacology DO - 10.1177/00912709922008515 UR - https://doi.org/10.1177/00912709922008515 ER -
APA
B, D., K, R., R, Y., F, A., D, C., E, F., B, G., C, S., SM, H., & LJ, L. (1999). FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.. Journal of clinical pharmacology. https://doi.org/10.1177/00912709922008515
Source records
- pubmed · retrieved 2026-09-25T14:40:38.667Z